LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Intravenous methotrexate at a dose of 1 g/m2 incorporated into RCHOP prevented CNS relapse in high‐risk DLBCL patients: A prospective, historic controlled study

Photo from wikipedia

Univ Lyon, University Claude Bernard Lyon 1, CNRS, INSA Lyon, CPE, Institute of Molecular and Supramolecular Chemistry and Biochemistry (ICBMS), Villeurbanne, France Univ Lyon, University Claude Bernard Lyon 1 EA… Click to show full abstract

Univ Lyon, University Claude Bernard Lyon 1, CNRS, INSA Lyon, CPE, Institute of Molecular and Supramolecular Chemistry and Biochemistry (ICBMS), Villeurbanne, France Univ Lyon, University Claude Bernard Lyon 1 EA 7424, Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM), Equipe “Biologie Vasculaire et du Globule Rouge”, Villeurbanne, France Laboratoire d'Excellence GR-Ex, Paris, France Laboratoire de Biochimie et de Biologie Moléculaire, UF de biochimie des pathologies érythrocytaires, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, Lyon, France Département de Médecine Interne, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France Institut d'Hématologie et d'Oncologie Pédiatrique, Hospices Civils de Lyon, Lyon, France

Keywords: lyon lyon; civils lyon; lyon; biologie; hospices civils; france

Journal Title: American Journal of Hematology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.